NanoVita Closes Pre-Series A as DeSci Funding Holds Steady

NanoVita closed an undisclosed Pre-Series A with K24 Ventures, LandScape Capital, and WestLabs Venture. Investors continue backing DeSci and on-chain health projects. 要点： • NanoVita secured Pre-Series A funding, adding to recent DeSci deal activity. • Investors remain willing to back health-focused Web3 projects despite the undisclosed raise amount. • The company did not reveal valuation, total capital raised, or how it will use the funds. • Multiple overlapping round announcements suggest phased fundraising—the staging remains unclear. • The company says it will use the funds for personalized health research and data sovereignty tools.